Literature DB >> 5962714

[Clinical-experimental study on the characterization of a cardiac glycoside].

J Hänel, G Meiffert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5962714

Source DB:  PubMed          Journal:  Med Welt        ISSN: 0025-8512


× No keyword cloud information.
  8 in total

1.  [Effect of proscillaridin-4'-methylether on pressure rise velocity in the left ventricle of patients with coronary heart disease (author's transl)].

Authors:  M Stauch; N Grewe; G G Belz
Journal:  Klin Wochenschr       Date:  1977-07-15

2.  Plasma levels after a single oral dose of proscillaridin.

Authors:  G G Belz; M Stauch; G Rudofsky
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

3.  [Plasma levels, elimination and cumulation of proscillaridin in renal failure (author's transl)].

Authors:  G G Belz; W J Brech
Journal:  Klin Wochenschr       Date:  1974-07-01

4.  On the pharmacokinetics of proscillaridin A in man.

Authors:  K E Andersson; A Bertler; A Redfors
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

5.  Metabolism and excretion of methylproscillaridin by man.

Authors:  N Rietbrock; R Staud
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

6.  Proscillaridin activity in portal and peripheral venous blood after oral administration to man.

Authors:  K E Andersson; B Bergdahl; H Dencker; G Wettrell
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

7.  Stability in vitro of methylproscillaridin.

Authors:  B Bergdahl; K E Andersson
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

8.  Pharmacokinetics and pharmacodynamics of methyl proscillaridin in healthy man.

Authors:  G G Belz; H Schreiter; G K Wolf
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.